High ROIC Stocks
RDY is currently part of our High ROIC Stocks screen, indicating it generates strong returns on invested capital.
DR. REDDY'S LABORATORIES-ADR (RDY) Stock Price & Overview
NYSE:RDY • US2561352038
Current stock price
13.09 USD
-0.21 (-1.58%)
At close:
13.1803 USD
+0.09 (+0.69%)
Pre-Market:
The current stock price of RDY is 13.09 USD. Today RDY is down by -1.58%. In the past month the price decreased by -4.87%. In the past year, price decreased by -5.08%.
RDY Key Statistics
52-Week Range12.81 - 16.17
Current RDY stock price positioned within its 52-week range.
1-Month Range12.83 - 13.97
Current RDY stock price positioned within its 1-month range.
- Market Cap
- 10.899B
- P/E
- 18.18
- Fwd P/E
- 21.67
- EPS (TTM)
- 0.72
- Dividend Yield
- 0.66%
RDY Stock Performance
Today
-1.58%
1 Week
-1.36%
1 Month
-4.87%
3 Months
-4.31%
Longer-term
6 Months -10.22%
1 Year -5.08%
2 Years -10.92%
3 Years +8.25%
5 Years -5.17%
10 Years +43.53%
RDY Stock Chart
RDY Stock Screens
RDY currently appears in the following ChartMill screener lists.
52-Week Low Stocks
RDY occurs in the near 52-week low stock list, indicating it is a potential value opportunity.
Peter Lynch Stocks
RDY appears in our Peter Lynch Stocks screen. This means the stock combines strong multi-year earnings growth with a reasonable valuation, solid profitability, and manageable debt, which are all characteristics often associated with a Peter Lynch-style investing approach.
RDY Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to RDY. When comparing the yearly performance of all stocks, RDY is a bad performer in the overall market: 76.72% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
RDY Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to RDY. While RDY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
RDY Earnings
On January 21, 2026 RDY reported an EPS of 14.53 and a revenue of 87.53B. The company beat EPS expectations (4.69% surprise) and beat revenue expectations (2.4% surprise).
Next Earnings DateMay 12, 2026
Last Earnings DateJan 21, 2026
PeriodQ3 / 2026
EPS Reported₹14.53
Revenue Reported87.534B
EPS Surprise 4.69%
Revenue Surprise 2.40%
RDY Forecast & Estimates
45 analysts have analysed RDY and the average price target is 14.57 USD. This implies a price increase of 11.31% is expected in the next year compared to the current price of 13.09.
For the next year, analysts expect an EPS growth of -7.77% and a revenue growth 6.7% for RDY
Analysts
Analysts67.56
Price Target14.57 (11.31%)
EPS Next Y-7.77%
Revenue Next Year6.7%
RDY Groups
Sector & Classification
RDY Financial Highlights
Over the last trailing twelve months RDY reported a non-GAAP Earnings per Share(EPS) of 0.72. The EPS increased by 3.81% compared to the year before.
Income Statements
Revenue(TTM)346.82B
Net Income(TTM)57.72B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.82% | ||
| ROA | 10.62% | ||
| ROE | 16.03% | ||
| Debt/Equity | 0.03 |
Chartmill High Growth Momentum
EPS Q2Q%-14.29%
Sales Q2Q%4.44%
EPS 1Y (TTM)3.81%
Revenue 1Y (TTM)11.06%
RDY Ownership
Ownership
Inst Owners52.17%
Shares832.59M
Float587.36M
Ins Owners1.23%
Short Float %2.49%
Short Ratio6.7
RDY Latest News, Press Relases and Analysis
a day ago - By: Chartmill
RDY Competitors/Peers
The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.31 | 869.14B | ||
| JNJ | JOHNSON & JOHNSON | 18.19 | 555.642B | ||
| MRK | MERCK & CO. INC. | 23 | 289.223B | ||
| PFE | PFIZER INC | 9.21 | 156.544B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.34 | 120.728B | ||
| ZTS | ZOETIS INC | 17.35 | 51.606B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.54 | 28.443B | ||
| VTRS | VIATRIS INC | 5.96 | 17.315B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.51 | 11.825B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.651B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.206B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.087B | ||
| CORT | CORCEPT THERAPEUTICS INC | 85.4 | 4.929B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About RDY
Company Profile
The company is headquartered in Hyderabad, Telangana and currently employs 26,944 full-time employees.
Company Info
IPO: 1986-01-01
DR. REDDY'S LABORATORIES-ADR
8-2-337, Road No.3 Banjara Hills
Hyderabad TELANGANA 500-034 IN
CEO: Erez Israeli
Employees: 26944
Phone: 914049002900
DR. REDDY'S LABORATORIES-ADR / RDY FAQ
What does DR. REDDY'S LABORATORIES-ADR do?
The company is headquartered in Hyderabad, Telangana and currently employs 26,944 full-time employees.
What is the current price of RDY stock?
The current stock price of RDY is 13.09 USD. The price decreased by -1.58% in the last trading session.
Does DR. REDDY'S LABORATORIES-ADR pay dividends?
DR. REDDY'S LABORATORIES-ADR (RDY) has a dividend yield of 0.66%. The yearly dividend amount is currently 0.09.
What is the ChartMill technical and fundamental rating of RDY stock?
RDY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the market expecting RDY stock to perform?
45 analysts have analysed RDY and the average price target is 14.57 USD. This implies a price increase of 11.31% is expected in the next year compared to the current price of 13.09.
What sector and industry does DR. REDDY'S LABORATORIES-ADR belong to?
DR. REDDY'S LABORATORIES-ADR (RDY) operates in the Health Care sector and the Pharmaceuticals industry.
How many employees does DR. REDDY'S LABORATORIES-ADR have?
DR. REDDY'S LABORATORIES-ADR (RDY) currently has 26944 employees.